Lonnel Coats was the CEO of Lexicon Pharmaceuticals for 10 years, retiring on July 7. Based in The Woodlands, United States.
Lonnel Coats was the CEO of Lexicon Pharmaceuticals for 10 years, retiring on July 7. Lexicon Pharmaceuticals reported significant revenue growth in Q1 2026, primarily driven by milestone payments from a licensing agreement with Novo Nordisk and sales of their heart failure treatment, INPEFA.
Full founder directory · Investor directory · Company funding database · Fundraising library